Background Endoscopic mucosal resection (EMR) involves forming a fluid cushion in the
submucosal area with a lifting agent, followed by superficial resection. Orise™ gel is one of …

The foundation of modern endoscopic mucosal resection (EMR) was laid in 1955 by a
surgeon named Norman Rosenberg. In his quest to increase safety during the fulguration of …

© AME Case Reports. All rights reserved. AME Case Rep 2023; 7: 11| https://dx. doi.
org/10.21037/acr-23-15 the FDA approved any submucosal injection fluid. Saline was the …

Background and Aims ORISE (Boston Scientific, Marlborough, Mass, USA) is a viscous gel
used for submucosal injection. We noted anecdotally that ORISE is associated with …

Background The Food and Drug Administration (FDA)-approved submucosal injection of
lifting agents such as ORISE® has become a widespread, routine and standard practice in …

Synthetic lifting media, ORISE™ gel and Eleview®, are increasingly used in gastrointestinal
endoscopy, but neither comparative features nor pitfalls are well-established. Media …

Background Submucosal injection of lifting solution is often performed to facilitate
endoscopic mucosal resection or endoscopic submucosal dissection. ORISE TM gel is a …

Context.—With the increasing development and use of iatrogenic agents, pathologists are
encountering more novel foreign materials in retrieved gastrointestinal specimens. These …

Background and Aims EMR and endoscopic submucosal dissection (ESD) are minimally
invasive endoscopic techniques, developed for the removal of benign and early malignant …

Bulking agent therapy has been trialed for various gastrointestinal diseases with mixed
success. There is currently a therapeutic roll in the endoscopic management of fecal …